Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.
A grade · PMID 42321916
View analysis →A grade · PMID 42372741
View analysis →A grade · PMID 42382416
View analysis →A grade · PMID 42150584
View analysis →This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 72.4/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 22.0; sample size: 90.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 72.3/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 54.2; sample size: 40.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 72.3/100. Study design: 60.0; human relevance: 85.0; therapeutic relevance: 51.5; sample size: 70.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 72.2/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 56.2; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 72.2/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 46.2; sample size: 40.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 72.2/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 36.2; sample size: 60.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 72.2/100. Study design: 90.0; human relevance: 100.0; therapeutic relevance: 16.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 72.2/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 91.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 72.1/100. Study design: 45.0; human relevance: 85.0; therapeutic relevance: 98.2; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 72.1/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 48.2; sample size: 90.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 72.1/100. Study design: 90.0; human relevance: 100.0; therapeutic relevance: 33.0; sample size: 20.0; recency: 100.0; abstract quality: 65.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 72.1/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 68.0; sample size: 50.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 72.1/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 48.0; sample size: 50.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 72.1/100. Study design: 95.0; human relevance: 75.0; therapeutic relevance: 18.0; sample size: 50.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 72.1/100. Study design: 75.0; human relevance: 90.0; therapeutic relevance: 28.0; sample size: 60.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 72.0/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 50.2; sample size: 30.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 72.0/100. Study design: 95.0; human relevance: 75.0; therapeutic relevance: 20.0; sample size: 60.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 72.0/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 40.0; sample size: 50.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 72.0/100. Study design: 95.0; human relevance: 75.0; therapeutic relevance: 20.0; sample size: 60.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 72.0/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 15.0; sample size: 100.0; recency: 100.0; abstract quality: 100.0.
